a highly conserved motif encompassing the active site, and the substitution significantly impairs ligase IV function (Riballo et al., 2001 ). The other two mutations are predicted to result in N-terminal amino acid substitutions, A3V and T9I. All three nucleotide substitutions were confirmed in genomic DNA from the patient. A parent and one unaffected sibling were heterozygous for the three mutations.
Mutations in LIG4 Confer an NBS-like Phenotype
We have previously described patients with clinical characteristics of NBS who do not have mutations in NBS1 and produce normal levels of nibrin protein (Cerosaletti et al., 1998; Hiel et al., 2001) . From 37 such patients screened, three additional patients with mutations in LIG4 were identified, two affected siblings from one family (patients 2303 and 2304) and a third unrelated patient (99P0149). Like patient 411BR, the patients displayed unusual facial features, microcephaly, growth and/or developmental delay, pancytopenia, and various skin abnormalities (Table 1) .
Both affected siblings, patients 2303 and 2304, are compound heterozygotes for two truncating mutations, 1738CϾT (R580X) and 2440CϾT (R814X). The former is predicted to result in loss of the C terminus encompassing the two Brct domains present in LIG4, while the latter lies in the region between the two Brct domains. The third patient, 99P0149, is a compound heterozygote for the mutation 1406GϾA resulting in an amino acid substitution, G469E, and the R814X mutation. We also observed seven individuals heterozygous for the 26CϾT substitution, two of whom were also heterozygous for 8CϾT. No patients homozygous for these substitutions, like 411BR, were observed. There were also two patients heterozygous for the silent substitution 1704TϾC and another heterozygous for 2465CϾT (5822L). SSCP analysis of XRCC4 from these "NBS-like" patient samples failed to detect any mutations that might have a functional impact. A previously reported polymorphism, 400T/C (I/T134), was detected in one patient (Ford et al., 2000) .
Impaired Expression of DNA Ligase IV in LIG4 Syndrome Patients
To examine the cellular impact of the truncating mutations, we used a lymphoblastoid cell line (LCL), LB 2304, derived from patient 2304, and a primary skin fibroblast cell line, FB2303, derived from the sibling. FB2303 showed similar radiosensitivity and defective DSB rejoining to that found in 411BR and 180BR (Figures 1 and  5 ). LB 2304 also displayed sensitivity in an assay that monitors radiosensitivity in LCLs as well as defective (Figure 2A) . As described below, the larger, 2). We also examined whether the two N-terminal amino although not the smaller, truncated protein is recognized acid substitutions, A3V and T9I, present in 411BR but by the ␣-ligase IV antibody used here. Anti-Xrcc4 immuabsent in 180BR, affect ligase IV function alone or ennoprecipitates were also examined in adenylation and hance the impact of the R278H mutation. Complexes ligation assays. As anticipated from the lack of detectcontaining the N-terminal substitutions, with or without able DNA ligase IV, no residual activity in either assay the R278H mutation, showed the same ability to interact was detected ( Figures 2B and 2C Figure 4C ). The R814X but in LB2304 cells was slightly greater than that observed not R580X protein was recognized by the anti-ligase in the LIG4 null cell line, N114-P2. We conclude that the IV antibody (SJA4), which was raised to a C-terminal stability of the truncated proteins in LB2304 is dramatifragment of ligase IV ( Figure 4B ). To investigate the abilcally decreased although the studies suggest that a low ity of the R814X protein to interact with Xrcc4, recombilevel of residual protein is expressed. nant complexes derived by coexpression with Xrcc4 were immunoprecipitated using anti-Xrcc4. A dramatiAnalysis of the Impact of the LIG4 Mutations cally reduced level of an 80 kDa protein was found in the Using Recombinant Mutant Protein anti-Xrcc4 immunoprecipitates obtained using R814X To examine the impact of the mutations on ligase IV mutant complexes in contrast to the signal obtained function, the mutations were introduced into LIG4 cDNA with WT complexes ( Figure 4D ). We conclude that R814X by site-directed mutagenesis, and the proteins were truncation markedly impairs interaction between Xrcc4 coexpressed with wild-type (WT) Xrcc4 using rabbit reand DNA ligase IV. Since the R580X protein has a similar ticulocyte lysates to derive WT or mutant ligase IV/Xrcc4 mobility to Xrcc4, we did not assess its ability to interact complexes. To examine the interaction with Xrcc4, rawith Xrcc4. diolabeled proteins were expressed and the presence Finally, we examined the R580X and R814X mutant of ligase IV was examined in anti-Xrcc4 immunoprecipicomplexes for nick ligation activity. In contrast to the tates. The activity of the recombinant complexes was WT complex, no activity above background could be examined using a nick ligation assay.
detected with either complex ( Figure 4B , lanes 5 and 7). DNA ligase IV expressed in the absence of Xrcc4 did Recombinant complexes containing the R278H muta-Expression of LIG4 cDNA Corrects the Defects in 411BR and FB2303 Cells To verify that defects in DNA ligase IV are responsible for the phenotypes described here, we used retroviral transduction to introduce LIG4 cDNA into FB2303 and 411BR primary fibroblasts. FB2303 cells infected with the LIG4 retrovirus, but not vector alone, expressed a similar level of full-length ligase IV to that observed in a control fibroblast cell line by Western blotting ( Figure  5A ). LIG4-infected FB2303 cells were fully corrected for radioresistance and DSB rejoining ( Figures 5B and 5C ). The nick ligation and adenylation activities of LIG4-infected FB2303 fibroblasts also returned to levels observed in control cells (data not shown). Infection of 411BR cells with the LIG4 retrovirus also restored expression of DNA ligase IV and normal radioresistance (data not shown).
LB2304 and 411BR Cells Have a Unique Defect in V(D)J Recombination
The frequency and fidelity of V(D)J recombination was examined in 411BRneo and LB2304 cells. The frequency of signal and coding join formation in 411BRneo cells was only marginally reduced compared to that obtained in control 1BR3neo cells but could not be assessed in LB2304 cells due to poor transfection efficiency ( Figure  6A ). Strikingly, we observed a significant change in signal join fidelity from 98% precision in 1BR3neo cells to less than 40% in 411BRneo and LB2304 cells ( Figure  6A ). Ten signal junctions sequenced from 411BR had deletions ranging from 18-35 with an average of 26 bp. We also observed a modest increase in the average size of deletions at 10 coding junctions sequenced from 411BRneo cells (7 to 27 nucleotides) compared to 1BR3neo cells (1 to 8 nucleotides).
Increased Spontaneous Chromosomal Breakage in Patient 2303
The analysis of chromosome breakage in lymphocytes has played an important role in diagnosis of A-T and Table 1 demonstrates that there is substantial phenotypic variation between the LIG4 syndrome patients that is likely related to the nature of the mutations. Since LIG4 null mutations in mice result in embryonic lethality, it is likely that the mutations described here are hypomorphic (Barnes et al., 1998; Gao et al., 1998) . Two of the mutations identified lead to protein truncations resulting in deletion of both Brct domains or the second Brct domain in addition to part of the intervening region between the two domains. The intervening region has been reported to be important for interaction with Xrcc4 (Grawunder et al., 1998b) . Consistent with this, the R814X mutation impairs interaction with Xrcc4. Only low residual ligase IV protein was detectable in cell lines expressing the two truncating mutations. Two factors, therefore, contribute to the defect in these patients: decreased levels of ligase IV and impaired interaction with ., 2000) . This raises the exciting possibility that our findings have broader significance and that defects in other damage response genes may be found within the group of NBS-like and Seckel-like patients. In this context, a patient defective in DNA ligase I also displayed growth delay and immunodeficiency (Barnes et al., 1992) . Alternatively, it is possible that nibrin, although not a core NHEJ component, may have an impact upon the same overall repair pathway. Finally, since the phenotype of LIG4 syndrome is due to defective repair, this raises the possibility that the developmental phenotype in NBS may also be attributable to the repair rather than the checkpoint defect.
An important characteristic of A-T and NBS is elevated cancer incidence, raising the question as to whether LIG4 syndrome is a cancer predisposition disorder. The et al., 1998a) . This suggests that a low level of residual 
